Qırmızı Qəsəbə

News and Video Search Results

News coverage

Rhythm Pharmaceuticals Announces Updates on MC4R Pathway Programs at R&D Event

-- Phase 3 trial evaluating setmelanotide in pediatric patients ages 2-

GlobeNewswire 06 Dec 2023

Transaction in Own Shares

*OSB GROUP PLC*
*ISIN:..

GlobeNewswire 31 May 2023

You might like